发明授权
US09518008B2 (1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof
有权
(1S,2S,3S,4R)-3 - [(1S)-1-乙酰氨基-2-乙基 - 丁基] -4- uan基-2-羟基 - 环戊基-1-羧酸水合物
- 专利标题: (1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof
- 专利标题(中): (1S,2S,3S,4R)-3 - [(1S)-1-乙酰氨基-2-乙基 - 丁基] -4- uan基-2-羟基 - 环戊基-1-羧酸水合物
-
申请号: US14511783申请日: 2014-10-10
-
公开(公告)号: US09518008B2公开(公告)日: 2016-12-13
- 发明人: Song Li , Wu Zhong , Zhibing Zheng , Xinbo Zhou , Junhai Xiao , Yunde Xie , Lili Wang , Xingzhou Li , Guoming Zhao , Xiaokui Wang , Hongying Liu
- 申请人: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A., China
- 申请人地址: CN Beijing
- 专利权人: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A., China
- 当前专利权人: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A., China
- 当前专利权人地址: CN Beijing
- 代理机构: Brinks Gilson & Lione
- 优先权: CN200710143607 20070814
- 主分类号: A61K31/196
- IPC分类号: A61K31/196 ; C07C279/16 ; C07C277/08 ; A61P31/16 ; C07C277/06
摘要:
The present invention relates to (1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentyl-1-carboxylic acid hydrates compounds, preparing methods thereof, pharmaceutical compositions containing said compounds and preparing methods thereof, and the clinical uses of said compounds as neuramidinase inhibitors for anti-influenza.
公开/授权文献
信息查询
IPC分类: